WG
CTSO icon

Winton Group’s Cytosorbents Corp CTSO Stock Holding History

Winton Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-25,678
Closed -$129K – 1590
2019
Q3 		$129K Buy
+25,678
New +$149K ﹤0.01% 1439
2019
Q2 		– Sell
-14,063
Closed -$106K – 1155
2019
Q1 		$106K Buy
+14,063
New +$110K ﹤0.01% 1029

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Winton Group's CTSO Position: Q4 2019 in Review

Winton Group sold out of Cytosorbents Corp (CTSO) in Q4 2019, closing a stake of 25,678 shares — an estimated $129K sold.

Winton Group first reported a position in CTSO in Q1 2019 and held it in 2 quarters. The position peaked at $129K in Q3 2019. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Winton Group reported no remaining Cytosorbents Corp position as of Q4 2019 after selling out during the quarter.
  • Winton Group sold 25,678 Cytosorbents Corp shares in Q4 2019, an estimated $129K.
  • Winton Group first reported a position in Cytosorbents Corp in Q1 2019 and held it in 2 quarters.
  • Winton Group's Cytosorbents Corp position peaked at $129K in Q3 2019.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Winton Group's 13F filing for Q4 2019, filed 13 Feb 2020.